These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11205369)

  • 21. Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
    Giffroy X; Maes N; Albert A; Maquet P; Crielaard JM; Dive D
    Acta Neurol Belg; 2017 Mar; 117(1):53-59. PubMed ID: 27194163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of MS disability by multimodal evoked potentials: investigation during relapse or in the relapse-free interval?
    Schlaeger R; D'Souza M; Schindler C; Grize L; Kappos L; Fuhr P
    Clin Neurophysiol; 2014 Sep; 125(9):1889-92. PubMed ID: 24555924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evoked potentials in multiple sclerosis.
    Kraft GH
    Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):717-20. PubMed ID: 24314688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of evoked potentials in the diagnosis and follow-up of multiple sclerosis.
    Drislane FW
    Clin Neurosci; 1994; 2(3-4):196-201. PubMed ID: 7749888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evoked potentials in neurology: a review of techniques and indications.
    Lascano AM; Lalive PH; Hardmeier M; Fuhr P; Seeck M
    J Neurol Neurosurg Psychiatry; 2017 Aug; 88(8):688-696. PubMed ID: 28235778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurophysiological and cognitive markers of disease evolution in multiple sclerosis.
    Comi G; Martinelli V; Locatelli T; Leocani L; Medaglini S
    Mult Scler; 1998 Jun; 4(3):260-5. PubMed ID: 9762686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology.
    Gronseth GS; Ashman EJ
    Neurology; 2000 May; 54(9):1720-5. PubMed ID: 10802774
    [No Abstract]   [Full Text] [Related]  

  • 28. Evoked potentials in the diagnosis of multiple sclerosis.
    Kjaer M
    Electroencephalogr Clin Neurophysiol Suppl; 1987; 39():291-6. PubMed ID: 3477437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
    Schlaeger R; Hardmeier M; D'Souza M; Grize L; Schindler C; Kappos L; Fuhr P
    Clin Neurophysiol; 2016 Mar; 127(3):1864-71. PubMed ID: 26754876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.
    Filippi M; Campi A; Mammi S; Martinelli V; Locatelli T; Scotti G; Amadio S; Canal N; Comi G
    J Neurol Neurosurg Psychiatry; 1995 Jan; 58(1):31-7. PubMed ID: 7823064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues.
    Skeen MB; Pani L
    J Clin Neurophysiol; 2021 May; 38(3):181-185. PubMed ID: 33958568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evoked potentials in clinical trials for multiple sclerosis.
    Emerson RG
    J Clin Neurophysiol; 1998 Mar; 15(2):109-16. PubMed ID: 9563577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurophysiological correlates of cognitive disturbances in multiple sclerosis.
    Leocani L; Gonzalez-Rosa JJ; Comi G
    Neurol Sci; 2010 Nov; 31(Suppl 2):S249-53. PubMed ID: 20842399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial recordings of multimodality evoked potentials in multiple sclerosis: a four year follow-up study.
    Iragui VJ; Wiederholt WC; Romine JS
    Can J Neurol Sci; 1986 Nov; 13(4):320-6. PubMed ID: 3779532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic skin response: correlation with autonomic and somatic involvement in multiple sclerosis.
    Caminero AB; Pérez-Jiménez A; Barreiro P; Ferrer T
    Electromyogr Clin Neurophysiol; 1995 Dec; 35(8):457-62. PubMed ID: 8773205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis in children: clinical, neuroimaging, and neurophysiological correlations.
    Wang PJ; Tseng CL; Young C; Liu HM; Chang YC; Shen YZ; Lee CY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):93-100. PubMed ID: 7793286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.
    Schlaeger R; D'Souza M; Schindler C; Grize L; Kappos L; Fuhr P
    Mult Scler; 2014 Jan; 20(1):51-6. PubMed ID: 23756680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evoked potentials in multiple sclerosis: recent experience at the Locomotor System Diseases Hospital].
    Brasil-Neto JP
    Arq Neuropsiquiatr; 1991 Jun; 49(2):204-7. PubMed ID: 1810240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evoked potentials in the diagnosis of multiple sclerosis: a follow up study.
    Matthews WB; Wattam-Bell JR; Pountney E
    J Neurol Neurosurg Psychiatry; 1982 Apr; 45(4):303-7. PubMed ID: 7077339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.
    Hardmeier M; Leocani L; Fuhr P
    Mult Scler; 2017 Sep; 23(10):1309-1319. PubMed ID: 28480798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.